124 related articles for article (PubMed ID: 34175567)
21. Venepuncture versus heel prick for the collection of the Newborn Screening Test.
Logan PW
Aust J Adv Nurs; 1999; 17(1):30-6. PubMed ID: 10776091
[TBL] [Abstract][Full Text] [Related]
22. The feasibility and cost of neonatal screening for prenatal alcohol exposure by measuring phosphatidylethanol in dried blood spots.
Bakhireva LN; Savich RD; Raisch DW; Cano S; Annett RD; Leeman L; Garg M; Goff C; Savage DD
Alcohol Clin Exp Res; 2013 Jun; 37(6):1008-15. PubMed ID: 23421919
[TBL] [Abstract][Full Text] [Related]
23. Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program.
Zytkovicz TH; Fitzgerald EF; Marsden D; Larson CA; Shih VE; Johnson DM; Strauss AW; Comeau AM; Eaton RB; Grady GF
Clin Chem; 2001 Nov; 47(11):1945-55. PubMed ID: 11673361
[TBL] [Abstract][Full Text] [Related]
24. Untargeted adductomics of newborn dried blood spots identifies modifications to human serum albumin associated with childhood leukemia.
Yano Y; Schiffman C; Grigoryan H; Hayes J; Edmands W; Petrick L; Whitehead T; Metayer C; Dudoit S; Rappaport S
Leuk Res; 2020 Jan; 88():106268. PubMed ID: 31760269
[TBL] [Abstract][Full Text] [Related]
25. Metabolomics in acute myeloid leukemia.
Wojcicki AV; Kasowski MM; Sakamoto KM; Lacayo N
Mol Genet Metab; 2020 Aug; 130(4):230-238. PubMed ID: 32457018
[TBL] [Abstract][Full Text] [Related]
26. Newborn Screening Samples for Diabetes Research: An Underused Resource.
Estrella JFGL; Immanuel J; Wiley V; Simmons D
Cells; 2020 Oct; 9(10):. PubMed ID: 33076340
[TBL] [Abstract][Full Text] [Related]
27. Quantification of glutamine in dried blood spots and plasma by tandem mass spectrometry for the biochemical diagnosis and monitoring of ornithine transcarbamylase deficiency.
Trinh MU; Blake J; Harrison JR; Gerace R; Ranieri E; Fletcher JM; Johnson DW
Clin Chem; 2003 Apr; 49(4):681-4. PubMed ID: 12651832
[No Abstract] [Full Text] [Related]
28. Short-term stability of amino acids and acylcarnitines in the dried blood spots used to screen newborns for metabolic disorders.
Golbahar J; Altayab DD; Carreon E
J Med Screen; 2014 Mar; 21(1):5-9. PubMed ID: 24531510
[TBL] [Abstract][Full Text] [Related]
29. Tandem mass spectrometry for the direct assay of enzymes in dried blood spots: application to newborn screening for Krabbe disease.
Li Y; Brockmann K; Turecek F; Scott CR; Gelb MH
Clin Chem; 2004 Mar; 50(3):638-40. PubMed ID: 14981030
[No Abstract] [Full Text] [Related]
30. The comparative analysis of serum proteomes for the discovery of biomarkers for acute myeloid leukemia.
Kwak JY; Ma TZ; Yoo MJ; Choi BH; Kim HG; Kim SR; Yim CY; Kwak YG
Exp Hematol; 2004 Sep; 32(9):836-42. PubMed ID: 15345285
[TBL] [Abstract][Full Text] [Related]
31. External validation of postnatal gestational age estimation using newborn metabolic profiles in Matlab, Bangladesh.
Murphy MS; Hawken S; Cheng W; Wilson LA; Lamoureux M; Henderson M; Pervin J; Chowdhury A; Gravett C; Lackritz E; Potter BK; Walker M; Little J; Rahman A; Chakraborty P; Wilson K
Elife; 2019 Mar; 8():. PubMed ID: 30887951
[TBL] [Abstract][Full Text] [Related]
32. [Preliminarily screening of serum characteristic markers in acute myeloid leukemia and clinical significance].
He AL; Bai J; Huang C; Zhang WG; Yang J; Wang JL; Meng X; Tian W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1132-7. PubMed ID: 21129246
[TBL] [Abstract][Full Text] [Related]
33. [Extensive neonatal heel injection screening for metabolic diseases in the Netherlands].
Visser G; van Spronsen FJ; de Sain-van der Velden MG; Blom HJ; Wijburg FA
Ned Tijdschr Geneeskd; 2009 May; 153(18):848-53. PubMed ID: 19475862
[No Abstract] [Full Text] [Related]
34. Assessment of the Diagnostic Potential of miR-29a-3p and miR-92a-3p as Circulatory Biomarkers in Acute Myeloid Leukemia.
Gado MM; Mousa NO; Badawy MA; El Taweel MA; Osman A
Asian Pac J Cancer Prev; 2019 Dec; 20(12):3625-3633. PubMed ID: 31870103
[TBL] [Abstract][Full Text] [Related]
35. The heel prick: how efficient is common practice?
Naughten F
RCM Midwives; 2005 Mar; 8(3):112-4. PubMed ID: 15790179
[TBL] [Abstract][Full Text] [Related]
36. Rapid diagnosis and prognosis of de novo acute myeloid leukemia by serum metabonomic analysis.
Wang Y; Zhang L; Chen WL; Wang JH; Li N; Li JM; Mi JQ; Zhang WN; Li Y; Wu SF; Jin J; Wang YG; Huang H; Chen Z; Chen SJ; Tang H
J Proteome Res; 2013 Oct; 12(10):4393-401. PubMed ID: 23998518
[TBL] [Abstract][Full Text] [Related]
37. Newborn screening blood spot analysis in the UK: influence of spot size, punch location and haematocrit.
Lawson AJ; Bernstone L; Hall SK
J Med Screen; 2016 Mar; 23(1):7-16. PubMed ID: 26113437
[TBL] [Abstract][Full Text] [Related]
38. Serum MicroRNA-370 as a potential diagnostic and prognostic biomarker for pediatric acute myeloid leukemia.
Lin X; Wang Z; Wang Y; Feng W
Int J Clin Exp Pathol; 2015; 8(11):14658-66. PubMed ID: 26823789
[TBL] [Abstract][Full Text] [Related]
39. Newborn "heel stick" screening: are you ready for the new ones?
Trachtman L; Myers C
J La State Med Soc; 2005; 157(4):210-3. PubMed ID: 16250372
[No Abstract] [Full Text] [Related]
40. Screening of newborns and high-risk group of children for inborn metabolic disorders using tandem mass spectrometry in South Korea: a three-year report.
Yoon HR; Lee KR; Kang S; Lee DH; Yoo HW; Min WK; Cho DH; Shin SM; Kim J; Song J; Yoon HJ; Seo S; Hahn SH
Clin Chim Acta; 2005 Apr; 354(1-2):167-80. PubMed ID: 15748614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
